ABBV vs AGL · P/E 81, rev $16.99B vs rev $2.92B
AbbVie Inc (ABBV) versus agilon health Inc (AGL) — a side-by-side from cached financials, not a winner call.
AbbVie Inc (ABBV) is a drug manufacturers - general company listed on US. It is led by Rob Michael.
agilon health Inc (AGL) is a medical care facilities company listed on US.
Latest reported ABBV revenue for 2026-06-30 was $16.99B. Net income was $3.61B. Revenue was up 13.3% from 2026-03-31 to 2026-06-30. ABBV currently screens at market cap $334.34B and trailing P/E 80.5.
Latest reported AGL revenue for 2026-06-30 was $2.92B. Net income was $66.9M. AGL currently screens at market cap $1.45B.
ABBV currently screens at market cap $334.34B and trailing P/E 80.5. AGL currently screens at market cap $1.45B.
Not investment advice. Open the ABBV and AGL stock pages for the full models.
Not investment advice.